Capstone Holding Corp. — Director's Dealing 2014

Feb 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2014-02-06

Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-06	Stock Option (Right to Buy)	$0.30	A	22000	Acquired	2024-02-06	Common Stock (22000)	Direct

Footnotes

F1: 50% to vest 2/6/2014 and 50% to vest monthly by 2/6/2015